Fonseca VA, Alvarado-Ruiz R, Raccah D, Boka G, Miossec P, Gerich JE
Start a Structured Medical Weight Loss Program Online with InjectCo Sustainable weight loss takes more than quick fixes or one-time solutions
The copper peptide concentration guide helps navigate optimal levels
GIP Agonism Reduces appetite, nausea, and bone resorption Increases insulin & glucagon production, and lipogenesis Glucagon Agonism Reduces appetite, food intake, and gastric emptying Increases insulin production, energy expenditure, and nausea Amylin Agonism Reduces appetite, food intake, glucagon production, and gastric emptying Increases energy expenditure Reduces bone resorption and increases bone production PYY Agonism Reduces appetite, food intake, and gastric emptying Increases energy expenditure and nausea The Cost Challenge for Payers The cost of GLP-1s continues to be a significant concern for payers between skyrocketing costs and utilization over the past several years
Appropriate for: Significantly higher BMI Large muscle mass athletes Areas with substantial subcutaneous fat Patient preference after consultation Caution: Higher risk of intramuscular injection
Does dehydration from GLP-1 side effects harm the kidneys